Post-approval studies (Phase 4)Active Not RecruitingNCT06282874
What this trial is testing
Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases
Who this might be right for
Carcinoma, Non-Small-Cell LungBrain MetastasesLeptomeningeal Metastasis
Guangdong Association of Clinical Trials 41